Biotech Firm Accused Of 'Gaslighting' In $41M Share Award Suit
An attorney for stockholders of biotech company Northwest Biotherapeutics argued Friday that the company deployed undated, after-the-fact notices to defend against a Delaware Chancery Court lawsuit accusing it of awarding directors...To view the full article, register now.
Already a subscriber? Click here to view full article